ContextVision presents Q2 2013 report
- New major ultrasound customer signed
- ContextVision wins important court ruling regarding patent litigation against Sapheneia.
Q2 FINANCIAL DATA
- Sales of 14.0 MSEK (16.0)
- Operating result of -1.9 MSEK (-3.0) and operating margin of -13.3% (-18.7%).
- Earnings per share of -0,18 (-0,37) SEK
A video presentation by CEO Anita Tollstadius will be released on Friday, Aug 23:rd.
Please follow the link: